Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function
- PMID: 1678600
- DOI: 10.1016/0006-291x(91)91051-d
Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function
Abstract
Malignant human glioma D-298 MG amplifies a rearranged epidermal growth factor receptor (EGFR) gene (c-erbB proto-oncogene), resulting in an in-frame deletion of 83 amino acids in domain IV of the extracellular domain of the EGFR. EGF and transforming growth factor-a (TGF-a) bound to the mutant EGFR with high affinity and enhanced the intrinsic mutant EGFR kinase activity. The mutant EGFR was capable of transducing EGF-stimulated glioma cell proliferation and invasiveness in an in vitro three-dimensional spheroid model. The deletion-mutant EGFR in D-298 MG is capable of being activated by growth factor; this suggests that overexpression of this mutant EGFR protein rather than structural alteration may be the more significant biologic event.
Similar articles
-
The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor.J Biol Chem. 1996 Mar 8;271(10):5850-8. doi: 10.1074/jbc.271.10.5850. J Biol Chem. 1996. PMID: 8621456
-
Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.Jpn J Cancer Res. 1999 Oct;90(10):1096-103. doi: 10.1111/j.1349-7006.1999.tb00683.x. Jpn J Cancer Res. 1999. PMID: 10595738 Free PMC article.
-
A chimeric EGFR/neu receptor in studies of neu function.Cancer Treat Res. 1992;61:213-28. doi: 10.1007/978-1-4615-3500-3_11. Cancer Treat Res. 1992. PMID: 1360234 Review. No abstract available.
-
A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2.EMBO J. 1992 Nov;11(11):3927-33. doi: 10.1002/j.1460-2075.1992.tb05486.x. EMBO J. 1992. PMID: 1356764 Free PMC article.
-
The epidermal growth factor receptor and its ligands.Cancer Treat Res. 1989;47:143-68. doi: 10.1007/978-1-4613-1599-5_6. Cancer Treat Res. 1989. PMID: 2576995 Review. No abstract available.
Cited by
-
EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?Curr Genomics. 2007 May;8(3):163-70. doi: 10.2174/138920207780833838. Curr Genomics. 2007. PMID: 18645600 Free PMC article.
-
Development of an EGFRvIII specific recombinant antibody.BMC Biotechnol. 2010 Oct 7;10:72. doi: 10.1186/1472-6750-10-72. BMC Biotechnol. 2010. PMID: 20925961 Free PMC article.
-
Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.Protein Sci. 2000 Feb;9(2):310-24. doi: 10.1110/ps.9.2.310. Protein Sci. 2000. PMID: 10716183 Free PMC article.
-
Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".Cells. 2017 Jun 2;6(2):13. doi: 10.3390/cells6020013. Cells. 2017. PMID: 28574446 Free PMC article. Review.
-
Targeting the epidermal growth factor receptor in the treatment of colorectal cancer: state of the art.Drugs. 2006;66(11):1441-63. doi: 10.2165/00003495-200666110-00003. Drugs. 2006. PMID: 16906777 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous